News and Events
Stay informed about RECOVER’s Long COVID research by reading the latest news and participating in upcoming events.
Featured News Item
RECOVER-VITAL clinical trial finds no benefit of extended duration of PAXLOVID for Long COVID
RECOVER researchers conducted a clinical trial to test whether PAXLOVID, an antiviral drug, could reduce Long COVID symptoms when taken for 15 or 25 days. The study enrolled 959 adults with Long COVID at 69 sites across the US.
News Release
38 Results
38 Results
R3 Seminar Recap: Advancing Long COVID Research by Fostering Collaboration between RECOVER and the All of Us Research Program
During the October 8th RECOVER Research Review (R3) Seminar, researchers described how RECOVER and the All of Us Research Program collaborate to advance our understanding of Long COVID. These different National Institutes of Health (NIH) initiatives are sharing health data and developing innovative tools to gain important insights from that data.
R3 Seminar Recap
Use of metformin in adults with diabetes linked to lower risk of Long COVID
Findings from this RECOVER study could inform future efforts to prevent Long COVID using repurposed prescription drugs.
News Release
RECOVER Research Update: August 2024
Six new RECOVER research publications report findings from the initiative’s pathobiology, observational, and electronic health record (EHR) studies.
Research Update
Study suggests reinfections from the virus that causes COVID-19 likely have similar severity as original
NIH-funded analysis of health record data shows severe reinfections often follow severe first infections.
Announcement
RECOVER expands its data collection efforts through the Digital Health Program
Information collected in real time will help researchers learn more about the daily lives of people affected by Long COVID.
Feature
Leadership Q&A: NIH to bolster RECOVER Long COVID research efforts
Gary Gibbons, M.D., Walter Koroshetz, M.D., and Jeanne Marrazzo, M.D., M.P.H. of the NIH answer questions about investing an additional $515 million in RECOVER's Long COVID research efforts.
Q&A
NIH to bolster RECOVER Long COVID research efforts through infusion of $515 million
This additional funding will build on and continue RECOVER's work to improve our understanding of and ability to diagnose, prevent, and treat Long COVID.
News Release
Obstructive sleep apnea associated with increased risks for Long COVID
RECOVER researchers examined more than 2.2 million Americans' health data to learn why some people are more likely to develop Long COVID.
News Release